NOTE 12. NONCONTROLLING INTEREST

Basis of presentation. Noncontrolling interest (“NCI”) represents the equity in consolidated subsidiaries that is not attributable, directly or indirectly, to the Company. The Company consolidates entities in which it holds a controlling financial interest and reports the portion of net income (loss), other comprehensive income (loss), and net assets attributable to the minority owners as noncontrolling interest in accordance with ASC 810, Consolidation. NCI is presented within total stockholders’ equity (deficit) on the consolidated balance sheets, separately from the equity attributable to the stockholders of FDCTech, Inc., and net income (loss) and comprehensive income (loss) attributable to NCI are presented separately on the face of the consolidated statements of operations and of comprehensive income (loss). Transactions with noncontrolling interest holders that do not result in a loss of control are accounted for as equity transactions, with no gain or loss recognized in net income; any difference between consideration and the carrying amount of the NCI acquired or relinquished is recognized directly in additional paid-in capital.

Subsidiaries with noncontrolling interests. The Company’s noncontrolling interests consist of the 49% minority interest in AD Advisory Services Pty Ltd. (“ADS”), held since the Company obtained control of ADS, and a 0.1% interest in Alchemy International Ltd. (“AIL”) arising from the Company’s consolidation of AIL effective October 29, 2025. The Company holds a controlling financial interest in each of these subsidiaries and consolidates their results, attributing the proportionate share of their earnings, other comprehensive income (loss), and net assets to the noncontrolling interest holders. No noncontrolling interest is recognized for wholly owned subsidiaries.

NOTE 12. NONCONTROLLING INTEREST (continued)

Changes in noncontrolling interest. The carrying amount of noncontrolling interest was $(2,794) at June 30, 2026. During the three months ended September 30, 2026, the Company attributed net income of $21,620 and foreign currency translation attributable to NCI of $(11,321), resulting in a noncontrolling interest balance of $7,505 at September 30, 2026. The carrying amount of noncontrolling interest was $33,323 at December 31, 2025; during the nine months ended September 30, 2026, the Company attributed net income (loss) of $(7,065) and foreign currency translation attributable to NCI of $(18,753), resulting in the same $7,505 balance at September 30, 2026. For the comparative periods, noncontrolling interest was $41,608 at June 30, 2025, and $16,820 at December 31, 2024, and the Company attributed net income of $79,765 and foreign currency translation of $(35,476) for the three months ended September 30, 2025, and net income of $113,542 and foreign currency translation of $(44,465) for the nine months ended September 30, 2025, resulting in a balance of $85,897 at September 30, 2025. The noncontrolling interest balances rolled forward above tie to the noncontrolling interest reported within stockholders’ equity (deficit) on the consolidated balance sheets and to the consolidated statements of stockholders’ equity (deficit).

The following table presents the activity in the noncontrolling interest balance for the three and nine months ended September 30, 2026, and 2025:

SCHEDULE OF NONCONTROLLING INTEREST